RU2018127642A3 - - Google Patents

Download PDF

Info

Publication number
RU2018127642A3
RU2018127642A3 RU2018127642A RU2018127642A RU2018127642A3 RU 2018127642 A3 RU2018127642 A3 RU 2018127642A3 RU 2018127642 A RU2018127642 A RU 2018127642A RU 2018127642 A RU2018127642 A RU 2018127642A RU 2018127642 A3 RU2018127642 A3 RU 2018127642A3
Authority
RU
Russia
Application number
RU2018127642A
Other languages
Russian (ru)
Other versions
RU2018127642A (ru
RU2737464C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018127642A publication Critical patent/RU2018127642A/ru
Publication of RU2018127642A3 publication Critical patent/RU2018127642A3/ru
Application granted granted Critical
Publication of RU2737464C2 publication Critical patent/RU2737464C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2018127642A 2015-12-30 2016-12-30 Системы и способы длительного трансдермального введения RU2737464C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562273288P 2015-12-30 2015-12-30
US62/273,288 2015-12-30
US201662367055P 2016-07-26 2016-07-26
US62/367,055 2016-07-26
PCT/US2016/069558 WO2017117554A1 (en) 2015-12-30 2016-12-30 Systems and methods for long term transdermal administration

Publications (3)

Publication Number Publication Date
RU2018127642A RU2018127642A (ru) 2020-02-03
RU2018127642A3 true RU2018127642A3 (enExample) 2020-05-13
RU2737464C2 RU2737464C2 (ru) 2020-11-30

Family

ID=57861282

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018127642A RU2737464C2 (ru) 2015-12-30 2016-12-30 Системы и способы длительного трансдермального введения

Country Status (12)

Country Link
US (6) US10966936B2 (enExample)
EP (1) EP3397250B1 (enExample)
JP (1) JP6833855B2 (enExample)
KR (1) KR102774558B1 (enExample)
CN (1) CN108697655B (enExample)
AU (2) AU2016381351B2 (enExample)
CA (1) CA3010183A1 (enExample)
IL (2) IL303255A (enExample)
MX (1) MX2018008190A (enExample)
RU (1) RU2737464C2 (enExample)
SG (1) SG11201805570WA (enExample)
WO (1) WO2017117554A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
WO2016145373A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
US10966936B2 (en) 2015-12-30 2021-04-06 Corium, Inc. Systems comprising a composite backing and methods for long term transdermal administration
CA3028436A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
MX2019001104A (es) 2016-07-27 2019-10-02 Corium Int Inc Sistemas de suministro transdermico de memantina.
WO2018022814A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
US9993466B2 (en) 2016-07-27 2018-06-12 Corium International, Inc. Donepezil transdermal delivery system
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11052054B2 (en) * 2017-04-19 2021-07-06 Inep Europe Sarl Method for manufacturing a transdermal device
US20180303764A1 (en) * 2017-04-19 2018-10-25 Inep Europe Sarl Method for manufacturing a transdermal device
CN111132669A (zh) * 2017-07-26 2020-05-08 考里安公司 具有带溶剂填充孔的微孔膜的透皮递送系统
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US20200121507A1 (en) 2018-10-18 2020-04-23 Moldex-Metric, Inc. Foam earplug with transdermal material
CN112206222A (zh) * 2018-11-09 2021-01-12 北京德默高科医药技术有限公司 含有布洛芬结构类似物的多层经皮给药系统
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
US12390422B2 (en) * 2019-06-28 2025-08-19 Passport Technologies, Inc. Transdermal drug delivery patch, drug delivery system and drug delivery
RU2705896C1 (ru) * 2019-07-26 2019-11-12 Артем Олегович Бахметьев Трансдермальный пластырь
US11471839B2 (en) * 2019-08-06 2022-10-18 Uop Llc High selectivity membranes for hydrogen sulfide and carbon dioxide removal from natural gas
WO2021211915A1 (en) * 2020-04-17 2021-10-21 University Of Connecticut Polycannabinoids, compounds, compositions and methods of use
US20210346207A1 (en) * 2020-05-11 2021-11-11 Marc Sheldon Stevens Four-way stretch therapeutic compress assembly, system, and method
US11596772B2 (en) * 2021-02-07 2023-03-07 Lumen Catheters, LLC Antimicrobial light-emitting percutaneous site dressing

Family Cites Families (265)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1880808A (en) 1927-03-28 1932-10-04 Eastman Kodak Co Process of making cellulose esters of carboxylic acids
US1683347A (en) 1927-08-25 1928-09-04 Eastman Kodak Co Process of making chloroform-soluble cellulose acetate
US1698049A (en) 1928-01-18 1929-01-08 Eastman Kodak Co Process of making cellulosic esters containing halogen-substituted fatty-acid groups
US1984147A (en) 1929-10-22 1934-12-11 Eastman Kodak Co Process for the production of cellulose esters and corresponding alkyl esters
US1880560A (en) 1929-12-14 1932-10-04 Eastman Kodak Co Process for the hydrolysis of cellulose acetate
US1943119A (en) 1929-12-17 1934-01-09 Westinghouse Electric & Mfg Co Circuitous elevator
US1939729A (en) 1930-01-29 1933-12-19 Thomas W Cohill Elevator system
US2129052A (en) 1936-02-04 1938-09-06 Eastman Kodak Co Hydrolyzed cellulose acetate
US3391142A (en) 1966-02-09 1968-07-02 Lilly Co Eli Adamantyl secondary amines
NL134681C (enExample) 1966-04-26
US3546141A (en) 1966-08-08 1970-12-08 Mc Donnell Douglas Corp Phosphorus-nitrogen polymers and process
US3493319A (en) 1967-05-26 1970-02-03 Us Agriculture Esterification of cellulosic textiles with unsaturated long chain fatty acids in the presence of trifluoroacetic anhydride using controlled cellulose-acid-anhydride ratios
US4004654A (en) 1971-07-07 1977-01-25 Trebron Holdings Limited Elevator structure supporting apparatus
CH603545A5 (enExample) 1972-04-20 1978-08-31 Merz & Co
DE2856393C2 (de) 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
US4752478A (en) 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
ATE45735T1 (de) 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
FR2576888B1 (fr) 1985-02-05 1988-04-08 Otis Elevator Co Ascenseur transbordeur pour voies urbaines notamment
US4756710A (en) 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
US4880633A (en) 1986-03-12 1989-11-14 Merck & Co., Inc. Transdermal drug delivery system
US4797284A (en) 1986-03-12 1989-01-10 Merck & Co., Inc. Transdermal drug delivery system
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
ATE71287T1 (de) * 1986-06-13 1992-01-15 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
US5686489A (en) 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US5071656A (en) 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US4787888A (en) 1987-06-01 1988-11-29 University Of Connecticut Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4837027A (en) 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
US4849224A (en) 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5026556A (en) 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5202128A (en) 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
CA2007181C (en) 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
ES2059602T3 (es) 1989-04-14 1994-11-16 Merz & Co Gmbh & Co Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
DE3913734C2 (de) 1989-04-26 1998-08-20 Roehm Gmbh Verwendung einer wäßrigen Hauthaftkleberlösung zur Herstellung einer mit Wasser leicht abwaschbaren Klebschicht
ATE107517T1 (de) 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
US5252588A (en) 1990-04-27 1993-10-12 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation
ATE111351T1 (de) 1990-07-23 1994-09-15 Alza Corp Oral anzuwendende osmotische vorrichtung zur abgabe von nicotin.
IT1243745B (it) 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US5614560A (en) 1991-04-04 1997-03-25 Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
US5123900A (en) * 1991-08-16 1992-06-23 Bertek, Inc. Moisture permeable double disk
US5246705A (en) 1992-04-08 1993-09-21 Cygnus Therapeutic System Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
JPH06199659A (ja) 1992-10-28 1994-07-19 Hisamitsu Pharmaceut Co Inc 経皮治療用装置
US5612411A (en) * 1992-11-18 1997-03-18 Kimberly-Clark Corporation Absorbent phycocolloids and a method for their manufacture
US5489624A (en) 1992-12-01 1996-02-06 Minnesota Mining And Manufacturing Company Hydrophilic pressure sensitive adhesives
DE4310012A1 (de) 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
JPH06321445A (ja) 1993-05-10 1994-11-22 Toshiba Corp エレベータ
US5424077A (en) 1993-07-13 1995-06-13 Church & Dwight Co., Inc. Co-micronized bicarbonate salt compositions
US5567489A (en) * 1993-09-16 1996-10-22 The Dow Chemical Company Multilayer halogen-free barrier film for ostomy and transdermal drug delivery applications
JP3135760B2 (ja) 1993-10-18 2001-02-19 株式会社竹中工務店 エレベータシステム
JPH07187525A (ja) 1993-11-18 1995-07-25 Masami Sakita 複数ばこエレベータシステム
JP4102901B2 (ja) 1994-09-14 2008-06-18 スリーエム カンパニー 経皮薬剤導入用マトリックス
US5557018A (en) 1994-09-27 1996-09-17 E. I. Du Pont De Nemours And Company Partially flourinated polymers and process therefor
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
CN1170360A (zh) 1994-12-21 1998-01-14 瑟垃技术有限公司 具有粘性贴面和剥离密封圆片的经皮输送系统
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
WO1996040087A2 (en) 1995-06-07 1996-12-19 Cygnus, Inc. Pressure sensitive acrylate adhesive composition cross-linked with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group
US5730900A (en) 1995-06-08 1998-03-24 Fuji Photo Film Co., Ltd. Film and process for preparation of the same and liquid crystal display
US5601156A (en) 1995-11-29 1997-02-11 Otis Elevator Company Maintaining communications and power during transfer of horizontally moveable elevator cab
US5785153A (en) 1995-11-29 1998-07-28 Otis Elevator Company Synchronizing elevator arrival at a level of a building
US5651426A (en) 1995-11-29 1997-07-29 Otis Elevator Company Synchronous elevator shuttle system
US5758748A (en) 1995-11-29 1998-06-02 Otis Elevator Company Synchronized off-shaft loading of elevator cabs
US5702720A (en) 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
TW513409B (en) 1996-06-07 2002-12-11 Eisai Co Ltd Polymorphs of donepezil hydrochloride
US5861586A (en) 1996-06-19 1999-01-19 Otis Elevator Company Horizontal and vertical passenger transport
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US5752585A (en) 1996-07-25 1998-05-19 Otis Elevator Company Elevator shuttle with auxiliary elevators at terminals
US5924524A (en) 1996-07-25 1999-07-20 Otis Elevator Company Integrated, multi-level elevator shuttle
US5958919A (en) 1996-09-20 1999-09-28 Washington University Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
ATE229817T1 (de) 1996-10-24 2003-01-15 Alza Corp Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
CN1174031A (zh) 1997-04-23 1998-02-25 谢先运 双氯芬酸钠透皮控释贴膏
US5866585A (en) 1997-05-22 1999-02-02 Synchroneuron, Llc Methods of treating tardive dyskinesia using NMDA receptor antagonists
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
US20040018241A1 (en) 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6193993B1 (en) 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
JP4205778B2 (ja) 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
DE19820999A1 (de) * 1998-05-11 1999-11-18 Lohmann Therapie Syst Lts Laminat zum Aufbringen auf einen Akzeptor
US6225348B1 (en) 1998-08-20 2001-05-01 Alfred W. Paulsen Method of treating macular degeneration with a prostaglandin derivative
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
AU5409699A (en) 1999-07-05 2001-01-22 Idea Ag A method for the improvement of transport across adaptable semi-permeable barriers
US6562368B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US20020192243A1 (en) 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
DE60142900D1 (de) 2000-07-07 2010-10-07 Corium Internat Inc Herstellung von hydrophilen druckempfindlichen klebstoffen mit optimalen hafteigenschaften
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
JP3962684B2 (ja) 2000-11-06 2007-08-22 サムヤン コーポレイション 改善された水分吸収能および接着性を有する経皮投与剤
JP4057418B2 (ja) 2000-11-07 2008-03-05 久光製薬株式会社 経皮吸収型製剤
JP4850346B2 (ja) 2001-03-15 2012-01-11 救急薬品工業株式会社 粘膜貼付剤
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
EP1390085B1 (en) 2001-05-01 2009-08-05 A.V. Topchiev Institute of Petrochemical Synthesis Hydrogel compositions
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
ATE502657T1 (de) 2001-05-01 2011-04-15 Av Topchiev Inst Petrochemical Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US20040024028A1 (en) 2001-08-02 2004-02-05 Burton Steven L. Method for reducing or eliminating smoking
NL1018729C2 (nl) 2001-08-09 2003-02-11 Tms Internat B V Flexibele aansluitmodule en modulair systeem voor het meten en doorgeven van sensorsignalen.
US7250394B2 (en) 2001-08-20 2007-07-31 Maiken Nedergaard Treatment of glial tumors with glutamate antagonists
JP2005501883A (ja) 2001-09-04 2005-01-20 トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル セルタコナゾールを含む爪の機能障害および疾患の治療用の膏薬
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
ITMI20012827A1 (it) 2001-12-28 2003-06-28 Fidia Farmaceutici Formulazioni adesive transdermiche di diclofenac sodico
US7273619B2 (en) 2002-01-17 2007-09-25 Samyang Corporation Transdermal composition of an antivomiting agent
US7217853B2 (en) 2002-05-24 2007-05-15 Corium International, Inc. Composition for cushions, wound dressings and other skin-contacting products
SG102714A1 (en) 2002-05-27 2004-03-26 Inventio Ag Elevator installation with several self-propelled cars and at least three elevator hoistways situated adjacently
CN100340395C (zh) 2002-08-30 2007-10-03 阿尔扎公司 多层层压背衬结构体
CN100339070C (zh) 2002-10-24 2007-09-26 莫茨药物股份两合公司 包含1－氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物
ATE352508T1 (de) 2002-11-26 2007-02-15 Thyssenkrupp Elevator Ag Verfahren zur steuerung einer aufzuganlage sowie aufzuganlage zur durchführung des verfahrens
ME00147B (me) 2003-02-21 2010-10-10 Schering Ag Uv-stabilni transdermalni flasteri
US7294376B2 (en) 2003-08-26 2007-11-13 The Goodyear Tire & Rubber Company Tire with indicia
EP1526103B1 (de) 2003-10-09 2012-01-11 Inventio AG Aufzugsanlage mit mehrstöckigen Kabinen für den Zonenbetrieb in einem Gebäude
PL1670433T3 (pl) 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
WO2005037157A1 (en) 2003-10-14 2005-04-28 Dermatrends, Inc. Enhancing transdermal administration of hydrophilic drugs
CN1870984A (zh) 2003-10-22 2006-11-29 莫茨药物股份两合公司 1－氨基环己烷衍生物用于调节淀粉样病变中原纤维生成Aβ肽的沉积的用途
EP1952824A1 (en) 2003-11-21 2008-08-06 Memory Pharmaceuticals Corporation Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors
US7176185B2 (en) 2003-11-25 2007-02-13 Tsrl, Inc. Short peptide carrier system for cellular delivery of agent
CN102764247B (zh) 2004-01-30 2016-04-20 考里安国际公司 递送活性剂的快速溶解膜
EP1715853A4 (en) 2004-02-17 2012-07-18 Transcept Pharmaceuticals Inc COMPOSITIONS FOR THE DISTRIBUTION OF HYPNOTICS IN THE FIELD OF MUNICHCHLEIMHÄUTE AND USE METHOD THEREOF
DE102004010516A1 (de) 2004-03-04 2005-09-22 Bayer Technology Services Gmbh Verbessertes Verfahren zur zeitlichen Dosierung von Arzneistoffen
US7670838B2 (en) 2004-05-24 2010-03-02 The Board Of Trustees Of The Leland Stanford Junior University Coupling of excitation and neurogenesis in neural stem/progenitor cells
JPWO2005115355A1 (ja) 2004-05-28 2008-03-27 久光製薬株式会社 貼付製剤
TW200616608A (en) 2004-07-09 2006-06-01 Forest Laboratories Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
EP1616832A3 (de) 2004-07-15 2006-07-12 Inventio Ag Auzugsanlage mit mindestens drei nebeneinander angeordneten, vertikalen Aufzugsschächten und Verfahren zum Betreiben einer solchen Aufzugsanlage
TWI343357B (en) 2004-07-22 2011-06-11 Inventio Ag Elevator installation with individually movable elevator cars and method for operating such an elevator installation
WO2006017807A2 (en) 2004-08-05 2006-02-16 Corium International, Inc. Adhesive composition
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
MX2007004315A (es) 2004-10-08 2008-03-11 Noven Pharma Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
EP1661560B1 (en) 2004-11-22 2008-11-05 Hisamitsu Pharmaceutical Co., Inc. Transdermal patch comprising a melting point lowering agent
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US20060171906A1 (en) 2004-12-21 2006-08-03 Corium International, Inc. Sustained release tooth whitening formulations and systems
US20060205822A1 (en) 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
US7462743B2 (en) 2005-01-11 2008-12-09 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphs of memantine hydrochloride
US20060163008A1 (en) 2005-01-24 2006-07-27 Michael Godwin Autonomous linear retarder/motor for safe operation of direct drive gearless, rope-less elevators
JP5084496B2 (ja) 2005-02-04 2012-11-28 久光製薬株式会社 経皮吸収貼付剤
US20060188558A1 (en) 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
BRPI0607017B8 (pt) 2005-04-06 2021-05-25 Adamas Pharmaceuticals Inc composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
EP1885741B1 (en) 2005-04-27 2011-09-14 Sederma S.A.S. Lys-thr dipeptides and their use
US7888422B2 (en) 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
EP2001671B1 (en) 2006-03-28 2010-05-19 Amcor Flexibles Transpac B.V.B.A. A multilayer film free of halogens which is impermeable to aroma compounds
CN1895242B (zh) 2006-04-13 2011-08-31 沈阳药科大学 双氯芬酸盐的透皮贴剂及制备方法
IL175338A0 (en) 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
US20070259029A1 (en) 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
ES2466647T3 (es) 2006-05-08 2014-06-10 Teikoku Seiyaku Co., Ltd. Preparación absorbible por vía transdérmica que comprende un agente contra la demencia
JP5097359B2 (ja) 2006-05-09 2012-12-12 久光製薬株式会社 ドネペジル経皮吸収型製剤
WO2007132476A2 (en) 2006-05-15 2007-11-22 Matrix Laboratories Limited A process for the preparation of memantine hydrochloride
TW200815045A (en) 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
US9248104B2 (en) 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
WO2008024408A2 (en) 2006-08-22 2008-02-28 Theraquest Biosciences, Inc. Pharmaceutical formulations of cannabinoids for application to the skin and method of use
EP2117521B1 (en) 2006-11-03 2012-06-27 Durect Corporation Transdermal delivery systems comprising bupivacaine
US20080107719A1 (en) 2006-11-08 2008-05-08 Sukhon Likitlersuang Transdermal drug delivery system
BRPI0719351A2 (pt) 2006-12-01 2014-01-07 Nitto Denko Corp Preparação adesiva estabilizada contendo donezepil
KR101408488B1 (ko) 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 경시적인 변색을 억제하는 방법
CN101573115B (zh) 2006-12-01 2012-06-06 日东电工株式会社 抑制含有多奈哌齐的贴剂着色的方法、及降低多奈哌齐类似物的生成量的方法
US20080226698A1 (en) 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
JP2008259629A (ja) 2007-04-11 2008-10-30 Hakujuji Co Ltd 傷保護材
JP5403948B2 (ja) 2007-06-07 2014-01-29 久光製薬株式会社 メマンチン含有経皮吸収製剤
BRPI0814697B8 (pt) 2007-07-10 2021-05-25 Agile Therapeutics Inc dispositivo de liberação de fármacos
WO2009026135A2 (en) 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
US9017301B2 (en) 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
CN100560157C (zh) * 2007-11-13 2009-11-18 重庆市生力医疗设备有限公司 超声波药贴
JP2009203213A (ja) 2008-02-28 2009-09-10 Kosumedei Seiyaku Kk 経皮吸収医薬組成物
DE102008013701A1 (de) 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
KR101454362B1 (ko) 2008-03-24 2014-10-23 아이큐어 주식회사 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제
EP2111857A1 (de) 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
US20090291127A1 (en) 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
EP2279739B2 (en) 2008-05-30 2018-02-28 Nitto Denko Corporation Donepezil-containing patch preparation and packaging thereof
MX2010013847A (es) * 2008-06-13 2011-03-15 Oragenics Inc Uso de bacteria productora de peroxido de hidrogeno para blanquear dientes.
TW201006625A (en) 2008-08-06 2010-02-16 Hou-Fei Hu Tool chuck for screwdriver
PE20100371A1 (es) 2008-10-31 2010-06-01 Lexicon Pharmaceuticals Inc Agonistas del receptor s1p para el tratamiento de malaria cerebral
EP2196197A1 (en) 2008-12-15 2010-06-16 Bouty S.P.A. Antiviral patch
US20100178037A1 (en) 2009-01-12 2010-07-15 Te-Wei Chen Display apparatus, video generation apparatus, and method thereof
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
CN101518599A (zh) * 2009-03-24 2009-09-02 沈阳药科大学 祖师麻提取物缓释贴剂及其制备方法
JP5758290B2 (ja) 2009-05-01 2015-08-05 久光製薬株式会社 経皮吸収型製剤
KR101325104B1 (ko) 2009-09-16 2013-11-07 주식회사 삼양바이오팜 경피 투여 제형 및 그 제조 방법
ES2652491T3 (es) 2009-10-21 2018-02-02 Teikoku Seiyaku Co., Ltd. Preparación que contiene donepecilo de absorción transdérmica
CN102048678A (zh) 2009-10-30 2011-05-11 北京隆旗生物科技有限公司 一种奥昔布宁的透皮吸收制剂及其制备方法与药物应用
GB0921481D0 (en) 2009-12-08 2010-01-20 Vectura Ltd Process and product
JP2012236773A (ja) 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
PT2519225E (pt) 2009-12-30 2015-07-27 Novartis Ag Tiras finas de nicotina extrudidas por fusão
US20100178307A1 (en) 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
US9370495B2 (en) 2010-02-24 2016-06-21 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
US20110244023A1 (en) 2010-03-30 2011-10-06 Phosphagenics Limited Transdermal delivery patch
JP5665861B2 (ja) 2010-04-28 2015-02-04 久光製薬株式会社 ドネペジル含有経皮吸収製剤
US9012511B2 (en) 2010-05-19 2015-04-21 Alkermes Pharma Ireland Limited Nanoparticulate cinacalcet compositions
DE102010024105A1 (de) 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
US20140370076A1 (en) 2010-06-30 2014-12-18 Nal Pharmaceuticals, Ltd. Transdermal drug delivery system containing donepezil
NZ605352A (en) 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
EP2599501B1 (en) 2010-07-29 2014-11-12 Hisamitsu Pharmaceutical Co., Inc. Medical adhesive patch
EP3434257A1 (en) 2010-07-29 2019-01-30 Allergan, Inc. Preservative free brimonidine and timolol solutions
BR112013008985A2 (pt) 2010-10-12 2016-07-05 Cerecor Inc composições antitussígenas compreendendo memantina
JP5813652B2 (ja) 2010-10-28 2015-11-17 久光製薬株式会社 経皮吸収型製剤
JP5699554B2 (ja) 2010-11-11 2015-04-15 富士通株式会社 ベクトル処理回路、命令発行制御方法、及びプロセッサシステム
US9844515B2 (en) 2010-11-17 2017-12-19 Hexal Ag Transdermal therapeutic system comprising buprenorphine
WO2012084969A1 (en) 2010-12-22 2012-06-28 Hexal Ag Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
EA201390980A1 (ru) 2010-12-29 2013-11-29 Фармафилм С.Р.Л. Лекарственный пластырь для улучшенного трансдермального проникновения диклофенака диэтиламмония
TWI433904B (zh) 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
CN102775476B (zh) 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
US8673338B2 (en) 2011-07-29 2014-03-18 Massachusetts Eye And Ear Infirmary Methods of delivering pharmaceutical agents
JP5820207B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP5808214B2 (ja) 2011-09-30 2015-11-10 株式会社トクヤマ 貼付剤
WO2013078608A1 (en) 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
JP6576039B2 (ja) 2011-12-21 2019-09-18 スリーエム イノベイティブ プロパティズ カンパニー オーバーレイライナを有する粘着パッチ組立体、並びにそれを作製するためのシステム及び方法
CA2861324A1 (en) 2012-01-27 2013-08-01 Agile Therapeutics, Inc. Transdermal hormone delivery
KR101239150B1 (ko) 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
US9408802B1 (en) 2012-03-22 2016-08-09 Prosolus, Inc. Seven day drug in adhesive transdermal delivery
US20140256690A1 (en) 2013-03-08 2014-09-11 Agile Therapeutics, Inc. Contraceptive method
US20140276479A1 (en) 2013-03-14 2014-09-18 Noven Pharmaceuticals, Inc. Transdermal drug delivery system with overlay
WO2014174564A1 (ja) 2013-04-22 2014-10-30 祐徳薬品工業株式会社 メマンチン含有経皮吸収型貼付製剤
ITTV20130057A1 (it) 2013-04-23 2014-10-24 Tarcisio Scomparin "sistema elevatore e traslatore con struttura a portale che impiega cremagliere e piu' vie di corsa verticali ed orizzontali di almeno una cabina di trasporto di persone e cose per il superamento di ostacoli sopraelevato e non."
JP5415645B1 (ja) 2013-06-28 2014-02-12 久光製薬株式会社 貼付剤の製造方法、貼付剤及び包装体
WO2015031552A1 (en) 2013-08-30 2015-03-05 3M Innovative Properties Company Estradiol containing transdermal drug delivery systems and compositions
WO2015042165A1 (en) 2013-09-17 2015-03-26 Corium International, Inc. Topical adhesive composition, and device, for improving aesthetic appearance of skin
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
EP3054933A4 (en) 2013-10-11 2017-03-15 Teikoku Pharma USA, Inc. Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
US11660344B2 (en) 2013-11-17 2023-05-30 Medrx Co., Ltd. Transdermal colloidal solution agent
WO2015084371A1 (en) 2013-12-05 2015-06-11 Otis Elevator Company Ropeless high-rise elevator installation approach
US20160304316A1 (en) 2013-12-05 2016-10-20 Otis Elevator Company High speed ropeless elevator with different number of hoistways up and down in a group
KR101485822B1 (ko) 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
DE102014201804A1 (de) 2014-01-31 2015-08-06 Thyssenkrupp Elevator Ag Verfahren zum Betreiben eines Aufzugsystems
JP2015151370A (ja) 2014-02-14 2015-08-24 日東電工株式会社 貼付製剤
WO2015137967A1 (en) 2014-03-14 2015-09-17 Otis Elevator Company Robust startup method for ropeless elevator
CA2951706A1 (en) 2014-06-24 2015-12-30 KAT Transdermals LLC Transdermal delivery system
CA2955241C (en) 2014-07-18 2023-03-28 Buzzz Pharmaceuticals Limited Oxymorphone transdermal patch
CN106687138B (zh) 2014-09-03 2021-10-15 日东电工株式会社 包含双膦酸盐剂的细胞性免疫用疫苗药物组合物
WO2016046675A1 (en) 2014-09-28 2016-03-31 Mohan M Alapati Compositions and methods for the treatment of neurological diseases
DE102014220966A1 (de) 2014-10-16 2016-04-21 Thyssenkrupp Elevator Ag Verfahren zum Betreiben einer Transportanlage sowie entsprechende Transportanlage
WO2016060888A1 (en) 2014-10-16 2016-04-21 Otis Elevator Company Lateral transfer station for elevator having a magnetic screw propulsion system
CN107106510A (zh) 2014-12-18 2017-08-29 Icure药品株式会社 含有多奈哌齐为有效成分的经皮吸收制剂
US11007086B2 (en) * 2014-12-30 2021-05-18 3M Innovative Properties Company Wound dressing with multiple adhesive layers
EP3310348B1 (en) 2015-06-22 2020-08-05 Corium, Inc. Transdermal adhesive composition comprising a poorly soluble therapeutic agent
US10017354B2 (en) 2015-07-10 2018-07-10 Otis Elevator Company Control system for multicar elevator system
US10370222B2 (en) 2015-07-16 2019-08-06 Otis Elevator Company Ropeless elevator system and a transfer system for a ropeless elevator system
JP6462880B2 (ja) 2015-07-27 2019-01-30 久光製薬株式会社 アセナピン含有貼付剤の製造方法
US10135299B2 (en) 2015-08-25 2018-11-20 Otis Elevator Company Elevator wireless power transfer system
US10486940B2 (en) 2015-08-25 2019-11-26 Otis Elevator Company Alignment system for an elevator car
CN106477429B (zh) 2015-08-25 2020-08-21 奥的斯电梯公司 电梯轿厢引导机构
CN106477431B (zh) 2015-09-01 2020-01-21 奥的斯电梯公司 电梯轿厢的轿厢室隔离
EP3138800B1 (en) 2015-09-01 2018-12-12 Otis Elevator Company Elevator wireless communication and power transfer system
US20170066623A1 (en) 2015-09-04 2017-03-09 Otis Elevator Company Ropeless elevator control system
CN106542392B (zh) 2015-09-16 2020-09-15 奥的斯电梯公司 电梯制动控制系统
AU2016231585B2 (en) 2015-09-25 2018-08-09 Otis Elevator Company Elevator component separation assurance system and method of operation
US10486939B2 (en) 2015-09-27 2019-11-26 Otis Elevator Company Breaking system for a hoisted structure and method of controlling braking a hoisted structure
US9598265B1 (en) 2015-09-28 2017-03-21 Smart Lifts, Llc Vertically and horizontally mobile elevator cabins
US10532908B2 (en) 2015-12-04 2020-01-14 Otis Elevator Company Thrust and moment control system for controlling linear motor alignment in an elevator system
US10966936B2 (en) 2015-12-30 2021-04-06 Corium, Inc. Systems comprising a composite backing and methods for long term transdermal administration
CN107055231A (zh) 2016-01-04 2017-08-18 奥的斯电梯公司 Mcrl系统中的门厅人群控制调度
CN105693556A (zh) 2016-03-01 2016-06-22 巴斯特医药科技（常州）有限公司 卡巴拉汀酒石酸盐的转化方法及其产物制成的贴片
CA3028436A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
MX2019001104A (es) 2016-07-27 2019-10-02 Corium Int Inc Sistemas de suministro transdermico de memantina.
WO2018022814A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
US9993466B2 (en) 2016-07-27 2018-06-12 Corium International, Inc. Donepezil transdermal delivery system
JP2018165790A (ja) 2017-03-28 2018-10-25 ブラザー工業株式会社 定着装置
CN111132669A (zh) 2017-07-26 2020-05-08 考里安公司 具有带溶剂填充孔的微孔膜的透皮递送系统
CA3085342A1 (en) 2017-12-13 2019-06-20 Corium, Inc. Method for depot creation during transdermal drug delivery
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
WO2023278979A2 (en) 2021-06-28 2023-01-05 Corium, Llc Combination therapy treatment using transdermal delivery system
EP4362921A2 (en) 2021-06-28 2024-05-08 Corium, LLC Corona discharge treated transdermal delivery system
CN120513081A (zh) 2022-12-28 2025-08-19 考里安有限责任公司 制备透皮递送系统的方法
IL321722A (en) 2022-12-28 2025-08-01 Corium Llc Premixing method for preparing a transdermal delivery system

Also Published As

Publication number Publication date
US20240108587A1 (en) 2024-04-04
JP6833855B2 (ja) 2021-02-24
WO2017117554A1 (en) 2017-07-06
US10966936B2 (en) 2021-04-06
IL260290B1 (en) 2023-07-01
US12161767B2 (en) 2024-12-10
CA3010183A1 (en) 2017-07-06
RU2018127642A (ru) 2020-02-03
AU2016381351B2 (en) 2022-09-29
US10835499B2 (en) 2020-11-17
US20210196650A1 (en) 2021-07-01
US11648214B2 (en) 2023-05-16
AU2016381351A1 (en) 2018-07-19
RU2737464C2 (ru) 2020-11-30
US20170189534A1 (en) 2017-07-06
US20170189348A1 (en) 2017-07-06
EP3397250C0 (en) 2024-09-25
SG11201805570WA (en) 2018-07-30
IL260290B2 (en) 2023-11-01
IL303255A (en) 2023-07-01
US20210023020A1 (en) 2021-01-28
EP3397250A1 (en) 2018-11-07
AU2022235539A1 (en) 2022-10-13
EP3397250B1 (en) 2024-09-25
US20240091168A1 (en) 2024-03-21
KR20180127315A (ko) 2018-11-28
KR102774558B1 (ko) 2025-03-04
MX2018008190A (es) 2018-11-12
US11679086B2 (en) 2023-06-20
CN108697655B (zh) 2021-12-10
US12168075B2 (en) 2024-12-17
CN108697655A (zh) 2018-10-23
IL260290A (en) 2018-07-31
JP2019504052A (ja) 2019-02-14

Similar Documents

Publication Publication Date Title
RU2018127642A3 (enExample)
BR112018005708A2 (enExample)
BR112017027358A2 (enExample)
BR112017027367A2 (enExample)
AU2022228198B1 (enExample)
BE2015C047I2 (enExample)
BE2015C044I2 (enExample)
BR0205695B1 (enExample)
BR0004687B1 (enExample)
CN303071155S (enExample)
BR0000695B1 (enExample)
BR0000126B1 (enExample)
CN303070805S (enExample)
CN303069550S (enExample)
BR0003928B1 (enExample)
BR0003686B1 (enExample)
CN303069082S (enExample)
BR0003401B1 (enExample)
CN303067975S (enExample)
CN303067945S (enExample)
BRPI0500916B1 (enExample)
BR9912272B1 (enExample)
BR0003746B1 (enExample)
BR0001536B1 (enExample)
BR0003751B1 (enExample)